GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...
MedPage Today on MSN
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
Looking back at 25 years of history in the USA Today coaches poll, a Boilermaker national championship would conter recent ...
Novo Nordisk (NVO) stock is in focus as the FDA OKs a label revison for the company's GLP-1 pill Rybelsus to cut ...
Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...
Ivonescimab’s progression-free survival data in non-small cell lung cancer bode well for an upcoming overall survival readout ...
The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete the approval process in one to two months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback